Aptevo Therapeutics Inc (APVO)

NASDAQ
5.52
-0.27(-4.66%)
After Hours
5.63
+0.11(+1.99%)
- Real-time Data
  • Volume:
    41,830
  • Bid/Ask:
    5.40/6.39
  • Day's Range:
    5.44 - 5.95

APVO Overview

Prev. Close
5.79
Day's Range
5.44-5.95
Revenue
11M
Open
5.86
52 wk Range
4.74-43.21
EPS
-6.82
Volume
41,830
Market Cap
27.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,452,960
P/E Ratio
-
Beta
6.44
1-Year Change
-83.32%
Shares Outstanding
4,898,034
Next Earnings Date
Mar 30, 2022
What is your sentiment on Aptevo Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Aptevo Therapeutics Inc Company Profile

Employees
58

Aptevo Therapeutics Inc. is a clinical-stage, research and development biotechnology company. The Company is focused on developing immunotherapeutic candidates for the treatment of different forms of cancer. The Company has two modular protein platforms of technology: ADAPTIR and ADAPTIR-FLEX. It is designed to generate monospecific, bispecific and multi-specific antibody candidates that are capable for the human immune system against cancer cells. The Company's lead product candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, are developed using the ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is developed using the ADAPTIR-FLEX modular protein technology platform. APVO436 is a recombinant, bispecific T-cell engaging antibody candidate that is designed to target CD123, CD3 and redirect T-cell cytotoxicity to the tumor.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Back to 15
    0
    • any prediction for today ?
      0
      • Crazy volume lets go!!! 30 for sure before close
        3
        • what are your thoughts about today guys?
          0
          • we are faaacked
            1
            • what will tomorrow bring...
              0
              • More than doubled AH!
                1
                • to 20$
                  0
                  • Company might crash in the next week. Take a look at how many institutional investors are shorting them.
                    4
                    • That institutional investor might have crashed.
                      0
                    • What do you think about IBIO? Thanx.
                      0
                    • LOL buyout at $50
                      0
                  • now is a good time to buy anyone?
                    0
                    • Cant Hurt. Expect a dip Monday and a big up later next week.
                      0
                  • Nice , let's see 5.50 already this week
                    0
                    • will this be a multiple day run up?
                      0
                      • What is pushing this up so much?
                        0
                        • Aptevo Therapeutics Signs Agreement for Up to $74.5 Million to Sell Hyperimmune Commercial Products
                          0
                        • thanks Fisum. this happened on mar 25, the spike, why does it show sep 1 on your comment?
                          0
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.